Study on Low Dose Chemotherapy Followed by Olaparib and Pembrolizumab for Metastatic Pancreatic Ductal Cancer | Clinical Trial

Study on Low Dose Chemotherapy Followed by Olaparib and Pembrolizumab for Metastatic Pancreatic Ductal Cancer | Clinical Trial | Right2Hope